Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Achim Rittmeyer

8PUBLICATIONS
28CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Tumour immunologyCancer diagnosisRadiation therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

Sort by Publication Date:
|Apr 06, 2026
Correction: Comparison of real-world efficacy and safety of nivolumab plus ipilimumab or pembrolizumab combined with platinum-based chemotherapy as first-line treatment for advanced non-small cell lung cancer in a German population.

Moritz Weber, Alexander Freiherr von Hammerstein-Equord, Manuela Weinreich

|Jan 31, 2026
Comparison of real-world efficacy and safety of nivolumab plus ipilimumab or pembrolizumab combined with platinum-based chemotherapy as first-line treatment for advanced non-small cell lung cancer in a German population.

Moritz Weber, Alexander Freiherr von Hammerstein-Equord, Manuela Weinreich

|May 30, 2025
Five-Year Survival Outcomes With Atezolizumab After Chemotherapy in Resected Stage IB-IIIA Non-Small Cell Lung Cancer (IMpower010): An Open-Label, Randomized, Phase III Trial.

Enriqueta Felip, Nasser Altorki, Caicun Zhou

|Jun 19, 2024
Therapeutic Patterns and Clinical Outcomes in Limited Disease Small Cell Lung Cancer: A Decade of Analysis at a Tertiary Cancer Center.

David Alexander Ziegler, Cecilia Christiane Cleve, Sonia Ziegler

|Nov 17, 2023
SKYSCRAPER-02: Tiragolumab in Combination With Atezolizumab Plus Chemotherapy in Untreated Extensive-Stage Small-Cell Lung Cancer.

Charles M Rudin, Stephen V Liu, Ross A Soo

|Jun 10, 2023

Tobias Raphael Overbeck, Annika Reiffert, Katja Schmitz

Pageof 2

Frequent Collaborators

2 joint publications

Tobias Raphael Overbeck

2 joint publications

Stefan Andreas

2 joint publications

Alexander Freiherr von Hammerstein-Equord

2 joint publications

Moritz Weber

2 joint publications

Martin Reck

1 joint publications

Charles M Rudin

1 joint publications

Stephen V Liu

1 joint publications

Shun Lu

1 joint publications

Min Hee Hong

1 joint publications

Chao-Hua Chiu

Frequent Collaborators

2 joint publications

Tobias Raphael Overbeck

2 joint publications

Stefan Andreas

2 joint publications

Alexander Freiherr von Hammerstein-Equord

2 joint publications

Moritz Weber

Top Related Videos

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
04:04

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer

Published on : Feb 12, 2017

11.1K
See more related videos

Top Related Videos

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
04:04

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer

Published on : Feb 12, 2017

11.1K
See more related videos